We have located links that may give you full text access.
Prognostic Value of Relative Adrenal Insufficiency During Cardiogenic Shock: A Prospective Cohort Study with Long-Term Follow-Up.
Shock 2016 July 26
BACKGROUND: Relative adrenal insufficiency (RAI) is common in ICU patients, particularly during septic shock (SS). Cardiogenic shock (CS) may share some pathophysiological features with SS. The aim of this study was to evaluate the prevalence and long-term prognosis of RAI during CS.
METHODS: Prospective observational study conducted in the intensive care and cardiology units in one university hospital in France. Patients meeting the criteria for CS without prior corticosteroid therapy were included. Total blood cortisol levels were assessed immediately before (T0) a short corticotropin stimulation test (0.25 mg iv of tetracosactrin) and 30 and 60 minutes afterward. Δmax was defined as the difference between the maximal value after the test and T0.
RESULTS: Of the 92 patients enrolled, 42 (46% (95%CI [36-56%]) died in hospital and 7 more died during a median follow-up of 616 [57-2,498] days, for an overall mortality rate of 53% (95%CI [43-63%]), Three groups were identified based on the corticotropin test: group 1 (T0 ≤798 nmol/l and Δmax >473 nmol/l), group 2 [(T0 >798 nmol/l and Δmax >473 nmol/l) or (T0 ≤798 nmol/l and Δmax ≤472 nmol/l)], and group 3 (T0 >798 nmol/l and Δmax ≤473 nmol/l) with an overall survival of 76%, 43% and 15%, respectively (log rank p = 0.003). In the multivariable analysis, adrenal non-response (group 3) was an independent predictor of mortality (p = 0.04), along with left ventricular ejection fraction, SAPS2 score, and cardiac arrest.
CONCLUSIONS: These data suggest that a short corticotropin test has a good prognostic value in CS and allows identifying patients at higher risk of death.
METHODS: Prospective observational study conducted in the intensive care and cardiology units in one university hospital in France. Patients meeting the criteria for CS without prior corticosteroid therapy were included. Total blood cortisol levels were assessed immediately before (T0) a short corticotropin stimulation test (0.25 mg iv of tetracosactrin) and 30 and 60 minutes afterward. Δmax was defined as the difference between the maximal value after the test and T0.
RESULTS: Of the 92 patients enrolled, 42 (46% (95%CI [36-56%]) died in hospital and 7 more died during a median follow-up of 616 [57-2,498] days, for an overall mortality rate of 53% (95%CI [43-63%]), Three groups were identified based on the corticotropin test: group 1 (T0 ≤798 nmol/l and Δmax >473 nmol/l), group 2 [(T0 >798 nmol/l and Δmax >473 nmol/l) or (T0 ≤798 nmol/l and Δmax ≤472 nmol/l)], and group 3 (T0 >798 nmol/l and Δmax ≤473 nmol/l) with an overall survival of 76%, 43% and 15%, respectively (log rank p = 0.003). In the multivariable analysis, adrenal non-response (group 3) was an independent predictor of mortality (p = 0.04), along with left ventricular ejection fraction, SAPS2 score, and cardiac arrest.
CONCLUSIONS: These data suggest that a short corticotropin test has a good prognostic value in CS and allows identifying patients at higher risk of death.
Full text links
Related Resources
Trending Papers
Obesity pharmacotherapy in older adults: a narrative review of evidence.International Journal of Obesity 2024 May 7
SGLT2 Inhibitors in Kidney Diseases-A Narrative Review.International Journal of Molecular Sciences 2024 May 2
Use of Intravenous Albumin: A Guideline from the International Collaboration for Transfusion Medicine Guidelines.Chest 2024 March 5
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app